senate Bill S569A

2011-2012 Legislative Session

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this bill?

Actions

view actions (4)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 17, 2012 print number 569a
amend and recommit to health
Jan 04, 2012 referred to health
Jan 05, 2011 referred to health

Bill Amendments

Original
A (Active)
Original
A (Active)

S569 - Bill Details

See Assembly Version of this Bill:
A283A
Current Committee:
Law Section:
Public Health Law
Laws Affected:
Add Art 27-CCC §2747, Pub Health L; add §§209-H & 630-c, Tax L; add §97-llll, St Fin L
Versions Introduced in 2009-2010 Legislative Session:
S1197A, A3075A

S569 - Bill Texts

view summary

Provides a program to promote leukemia, lymphoma and myeloma research education and treatment and establishes the leukemia, lymphoma and myeloma research education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift an individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

view sponsor memo
BILL NUMBER:S569

TITLE OF BILL:
An act
to amend the public health law, the
tax law and the state finance law, in relation to providing
for taxpayer gifts for leukemia, lymphoma and myeloma
research, education and treatment and establishing
the leukemia research, education and treatment fund

PURPOSE OR GENERAL IDEA OF BILL:
The purpose of this bill is to
provide easy access to help fund and support Leukemia, Lymphoma, and
Myeloma research, education and treatment.

SUMMARY OF SPECIFIC PROVISIONS:
Section 1 - Amends the public health
law by adding a new article 27-CCC. The new article provides the
Commissioner of Health with the powers to: develop programs
concerning Leukemia, Lymphoma, and Myeloma, to accept and expend
grants, awards and other funding, and to enter into contracts
necessary for program development and granting. Section 2 - Amends
the law by adding a new section 209-H. The new section provides for
the Commissioner of Taxation and Finance to include a space on the
corporate income tax return for contributions to Leukemia, Lymphoma,
and Myeloma research, education and treatment. Section 3 - Amends
part 2 of article 22 of the tax law by adding new section 630-c. The
new section provides for the Commissioner of Taxation and Finance to
include a space on the individual income tax return for contributions
to Leukemia, Lymphoma, and Myeloma research, education and treatment.
Section 4 - Amends the state finance law by adding a new section
97-kkkk. The new section provides for the establishment of a special
fund, consisting of revenues received under section 209-H and 630-c
of the tax law and any other moneys appropriated, credited or
transferred, for Leukemia, Lymphoma and Myeloma research,
education and treatment. The custody of this fund will be held
jointly by the Commissioner of Taxation and Finance and the
Comptroller. Further, the new section provides that all monies in the
fund to be used only for Leukemia, Lymphoma and Myeloma research,
education and treatment programs approved by the Department of
Health. Additionally, the new section provides that the Comptroller
must approve releases of money that are certified by the Commissioner
of Health and that all money in the fund should be used prior to the
end of the fiscal year.

JUSTIFICATION:
Research and treatment efforts for many diseases,
including Alzheimer's and breast cancer, have benefited from
additional funding resulting from having a "check-off box" placed on
the individual and corporate income tax returns. Leukemia, Lymphoma
and Myeloma are blood cancers originating in the bone marrow and
correlate with each other because of the unrestrained growth of the
cells and the parallel functions which they possess.
Leukemia, although more common in adults over the age of 64, is still
the leading cause of disease death of children under 15 yrs old, with
Acute Lymphocytic Leukemia (ALL) being the most common form of


Leukemia in children. Treatment advances for Leukemia have proven to
be prevalent in the survival rate over the years, with the survival
rate increasing from 4% in 1960 to 85% in 1999. Lymphoma involves two
particular forms including Non-Hodgkin, which is the fifth most
common cancer in the U.S. and Hodgkin Lymphoma, which mostly affects
adolescents and young adults. Myeloma occurs mostly in people over 60
yrs old with males having a 50% higher chance than females of being
diagnosed. Each year an estimated 106,200 people in the United States
are diagnosed with Leukemia, Lymphoma, or Myeloma. At the present
time, an estimated 670,950 Americans have blood cancers.
Approximately 57,500 Americans will die from these hematological
malignancies this year. In New York State alone, there are
approximately 6,600 people diagnosed with a blood cancer each year
and 3,500 people will succumb to this disease.

PRIOR LEGISLATIVE HISTORY:
2010: A.3075-A Died on 3rd Rdg. S.1197-A - Died in Senate Health
2009: A.3075 Passed Assembly;
2008: A.1558-C Passed Assembly; S.3097-B - Died in Senate Health
2007: A.1558-A Passed Assembly; S.3097-A - Died in Senate Health
2006: A.3338-A Passed Assembly; S.2871-A - Died in Senate Health;
2005: A.3338-Passed Assembly; S-2878-A - Died in Senate Health
2004: A.9816-Passed Assembly; S.6491 - Died in Senate Health

FISCAL IMPLICATIONS:
Minimal to the state.

EFFECTIVE DATE:
This act shall apply to taxable years commencing on or
after January 1, 2013.

view full text
download pdf
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                   569

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 5, 2011
                               ___________

Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma and myeloma research, education and treatment and establishing  the
  leukemia research, education and treatment fund

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The public health law is amended by adding  a  new  article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION  2747.  LEUKEMIA,  LYMPHOMA  AND MYELOMA RESEARCH, EDUCATION AND
               TREATMENT.
  S 2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
MENT.   THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA AND MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION,  THE  COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1.  TO  PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS DESIGNED TO
REDUCE OR PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA,  LYMPHOMA  AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS  AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS AS
TO THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE  FUNDS
BY THE STATE FINANCE LAW; AND
  3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
  S 2. The tax law is amended by adding a new section 209-H to  read  as
follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00530-01-1

S. 569                              2

  S  209-H.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND  THIRTEEN, A TAXPAYER IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH,  EDUCATION  AND  TREATMENT FUND. SUCH CONTRIBUTION SHALL BE IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED BY SUCH TAXPAYER. THE  COMMISSIONER  SHALL  INCLUDE  SPACE  ON  THE
CORPORATE  INCOME  TAX RETURN TO ENABLE A TAXPAYER TO MAKE SUCH CONTRIB-
UTION.  NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL   REVENUES
COLLECTED  PURSUANT  TO  THIS SECTION SHALL BE CREDITED TO THE LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-KKKK  OF
THE STATE FINANCE LAW.
  S  3.  The tax law is amended by adding a new section 630-c to read as
follows:
  S 630-C. GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION
AND  TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANU-
ARY FIRST, TWO THOUSAND THIRTEEN, AN INDIVIDUAL IN ANY TAXABLE YEAR  MAY
ELECT  TO  CONTRIBUTE  TO  THE  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH,
EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION SHALL BE  IN  ANY  WHOLE
DOLLAR  AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY SUCH
INDIVIDUAL. THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL  INCOME
TAX  RETURN  TO  ENABLE  A TAXPAYER TO MAKE SUCH CONTRIBUTION.  NOTWITH-
STANDING ANY OTHER PROVISION OF LAW ALL REVENUES COLLECTED  PURSUANT  TO
THIS  SECTION  SHALL  BE  CREDITED TO THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE  PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-KKKK OF THE STATE FINANCE LAW.
  S  4. The state finance law is amended by adding a new section 97-kkkk
to read as follows:
  S 97-KKKK. LEUKEMIA, LYMPHOMA  AND  MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT  FUND.  1. THERE IS HEREBY ESTABLISHED IN THE JOINT CUSTODY OF
THE COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A  SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2.  SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE DEPARTMENT
OF TAXATION AND FINANCE, PURSUANT  TO  THE  PROVISIONS  OF  SECTION  TWO
HUNDRED  NINE-H  AND SECTION SIX HUNDRED THIRTY-C OF THE TAX LAW AND ALL
OTHER MONEYS APPROPRIATED, CREDITED, OR  TRANSFERRED  THERETO  FROM  ANY
OTHER  FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3. MONIES OF THE FUND SHALL BE EXPENDED ONLY  FOR  LEUKEMIA,  LYMPHOMA
AND  MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN THIS
SECTION, "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING  GRANTS  FOR  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND
TREATMENT, WHICH, PURSUANT TO SECTION TWENTY-SEVEN  HUNDRED  FORTY-SEVEN
OF  THE  PUBLIC  HEALTH  LAW,  ARE APPROVED BY THE DEPARTMENT OF HEALTH.
SUCH GRANTS MAY INCLUDE, AMONG OTHERS,  GRANTS  TO  PUBLIC  AND  PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.

S. 569                              3

  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2013.

S569A (ACTIVE) - Bill Details

See Assembly Version of this Bill:
A283A
Current Committee:
Law Section:
Public Health Law
Laws Affected:
Add Art 27-CCC §2747, Pub Health L; add §§209-H & 630-c, Tax L; add §97-llll, St Fin L
Versions Introduced in 2009-2010 Legislative Session:
S1197A, A3075A

S569A (ACTIVE) - Bill Texts

view summary

Provides a program to promote leukemia, lymphoma and myeloma research education and treatment and establishes the leukemia, lymphoma and myeloma research education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift an individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

view sponsor memo
BILL NUMBER:S569A

TITLE OF BILL:
An act
to amend the public health law, the
tax law and the state finance law, in relation to providing
for taxpayer gifts for leukemia, lymphoma and myeloma
research, education and treatment and establishing
the leukemia research, education and treatment fund

PURPOSE OR GENERAL IDEA OF BILL:
The purpose of this bill is to
provide easy access to help fund and support Leukemia, Lymphoma and
Myeloma research, education and treatment.

SUMMARY OF SPECIFIC PROVISIONS:
Section 1 - Amends the public health
law by adding a new article 27-CCC. The new article provides the
Commissioner of Health with the powers to: develop programs
concerning Leukemia, Lymphoma, and Myeloma, to accept and expend
grants. awards and other funding, and to enter into contracts
necessary for program development and granting. Section 2 - Amends
the law by adding a new section 209-H. The new section provides for
the Commissioner of Taxation and Finance to include a space on the
corporate income tax return for contributions to Leukemia, Lymphoma,
and Myeloma research.
education and treatment. Section 3 - Amends part 2 of article 22 of
the tax law by adding new section 630-c. The new section provides for
the Commissioner of Taxation and Finance to include a space on the
individual income tax return for contributions to Leukemia, Lymphoma,
and Myeloma research. education and treatment. Section 4 - Amends the
state finance law by adding a new section 97-1111. The new section
provides for the establishment of a special fund.
consisting of revenues received under section 209-H and 630-c of the
tax law and any other moneys appropriated. credited or transferred,
for Leukemia, Lymphoma and Myeloma research, education and treatment.
The custody of this fund will be held jointly by the Commissioner of
Taxation and Finance and the Comptroller. Further, the new section
provides that all monies in the fund to be used only for Leukemia,
Lymphoma and Myeloma research, education and treatment programs
approved by the Department of Health. Additionally, the new section
provides that the Comptroller must approve releases of money that are
certified by the Commissioner of Health and that all money in the
fund should be used prior to the end of the fiscal year.

JUSTIFICATION:
Research and treatment efforts for many diseases,
including Alzheimer's and breast cancer, have benefited from
additional funding resulting from having a "check-off box" placed on
the individual and corporate income tax returns. Leukemia, Lymphoma
and Myeloma are blood cancers originating in the bone marrow and
correlate with each other because of the unrestrained growth of the
cells and the parallel functions which they possess.
Leukemia. although more common in adults over the age of 64, is still
the leading cause of disease death of children under 15 yrs old, with
Acute Lymphocytic Leukemia (ALL) being the most common form of


Leukemia in children. Treatment advances for Leukemia have proven to
be prevalent in the survival rate over the years, with the survival
rate increasing from 4% in 1960 to 85% in 1999. Lymphoma involves two
particular forms including Non-Hodgkin. which is the fifth most
common cancer in the U.S. and Hodgkin Lymphoma, which mostly affects
adolescents and young adults. Myeloma occurs mostly in people over 60
yrs old with males having a 50% higher chance than females of being
diagnosed. Each year an estimated 106,200 people in the United States
are diagnosed with Leukemia, Lymphoma, or Myeloma. At the present
time. an estimated 670,950 Americans have blood cancers.
Approximately 57,500 Americans will die from these hematological
malignancies this year. In New York State alone, there are
approximately 6,600 people diagnosed with a blood cancer each year
and 3,500 people will succumb to this disease.

PRIOR LEGISLATIVE HISTORY:
2011: A.283 Passed Assembly S.569 - Died in Senate Health
2010: A.3075A Died on 3rd Rdg. S.1197A - Died in Senate Health
2009: A.3075 Passed Assembly
2008: A.1558C Passed Assembly; S.3097B - Died in Senate Health
2007: A.1558A Passed Assembly; S.3097A - Died in Senate Health
2006: A.3338A Passed Assembly; S.2871A - Died in Senate Health;
2005: A.3338 Passed Assembly; S.2878A - Died in Senate Health
2004: A.9816 Passed Assembly; S.6491 - Died in Senate Health

FISCAL IMPLICATIONS:
Minimal to the state.

EFFECTIVE DATE:
This act shall apply to taxable years commencing on or
after January 1, 2014.

view full text
download pdf
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 569--A

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 5, 2011
                               ___________

Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health --  recommitted  to
  the  Committee  on  Health in accordance with Senate Rule 6, sec. 8 --
  committee discharged, bill amended, ordered reprinted as  amended  and
  recommitted to said committee

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma  and myeloma research, education and treatment and establishing the
  leukemia research, education and treatment fund

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION 2747. LEUKEMIA, LYMPHOMA AND  MYELOMA  RESEARCH,  EDUCATION  AND
               TREATMENT.
  S  2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT.  THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A  PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA  AND  MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION, THE COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1. TO PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS  DESIGNED  TO
REDUCE  OR  PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA, LYMPHOMA AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS  AS
TO  THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE FUNDS
BY THE STATE FINANCE LAW; AND

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00530-03-2

S. 569--A                           2

  3. TO ENTER INTO CONTRACTS WITHIN THE AMOUNTS  AVAILABLE  THEREFOR  AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
  S  2.  The tax law is amended by adding a new section 209-H to read as
follows:
  S 209-H. GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION
AND  TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANU-
ARY FIRST, TWO THOUSAND FOURTEEN, A TAXPAYER IN  ANY  TAXABLE  YEAR  MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH,  EDUCATION  AND  TREATMENT FUND. SUCH CONTRIBUTION SHALL BE IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED BY SUCH TAXPAYER. THE  COMMISSIONER  SHALL  INCLUDE  SPACE  ON  THE
CORPORATE  INCOME  TAX RETURN TO ENABLE A TAXPAYER TO MAKE SUCH CONTRIB-
UTION.  NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL   REVENUES
COLLECTED  PURSUANT  TO  THIS SECTION SHALL BE CREDITED TO THE LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-LLLL  OF
THE STATE FINANCE LAW.
  S  3.  The tax law is amended by adding a new section 630-c to read as
follows:
  S 630-C. GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION
AND  TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANU-
ARY FIRST, TWO THOUSAND FOURTEEN, AN INDIVIDUAL IN ANY TAXABLE YEAR  MAY
ELECT  TO  CONTRIBUTE  TO  THE  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH,
EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION SHALL BE  IN  ANY  WHOLE
DOLLAR  AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY SUCH
INDIVIDUAL. THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL  INCOME
TAX  RETURN  TO  ENABLE  A TAXPAYER TO MAKE SUCH CONTRIBUTION.  NOTWITH-
STANDING ANY OTHER PROVISION OF LAW ALL REVENUES COLLECTED  PURSUANT  TO
THIS  SECTION  SHALL  BE  CREDITED TO THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE  PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF THE STATE FINANCE LAW.
  S  4. The state finance law is amended by adding a new section 97-llll
to read as follows:
  S 97-LLLL. LEUKEMIA, LYMPHOMA  AND  MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT  FUND.  1. THERE IS HEREBY ESTABLISHED IN THE JOINT CUSTODY OF
THE COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A  SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2.  SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE DEPARTMENT
OF TAXATION AND FINANCE, PURSUANT  TO  THE  PROVISIONS  OF  SECTION  TWO
HUNDRED  NINE-H  AND SECTION SIX HUNDRED THIRTY-C OF THE TAX LAW AND ALL
OTHER MONEYS APPROPRIATED, CREDITED, OR  TRANSFERRED  THERETO  FROM  ANY
OTHER  FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3. MONIES OF THE FUND SHALL BE EXPENDED ONLY  FOR  LEUKEMIA,  LYMPHOMA
AND  MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN THIS
SECTION, "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING  GRANTS  FOR  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND
TREATMENT, WHICH, PURSUANT TO SECTION TWENTY-SEVEN  HUNDRED  FORTY-SEVEN
OF  THE  PUBLIC  HEALTH  LAW,  ARE APPROVED BY THE DEPARTMENT OF HEALTH.
SUCH GRANTS MAY INCLUDE, AMONG OTHERS,  GRANTS  TO  PUBLIC  AND  PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.

S. 569--A                           3

  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.
  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2014.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.